Ablacon is a series b startup. 2 investors tracked. Status: possibledead.
Based in the United States, Ablacon is a startup. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Ablacon is a medical technology company focused on developing advanced solutions for cardiac ablation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.